First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. | First, the phase 3 trial of ...

Contagious diseases like measles, COVID-19, influenza, norovirus, and tuberculosis pose significant global health challenges.

Outbreaks of norovirus, an extremely contagious stomach bug, can spread quickly. “‘Tis the season for germs,” said Dr.

Dynavax is paying $30 million upfront for global rights to Vaxart’s investigational oral COVID-19 vaccine candidate, positioning the biotech to see phase 2b data before placing a bigger bet on the ...

A recent Indian Council of Medical Research (ICMR) study made some shocking revelations. It discovered that one in nine ...

A hospital is "extremely busy" with growing numbers of norovirus, flu and Covid cases. University Hospitals Sussex NHS Foundation Trust said high numbers of people are attending Worthing Hospital. Due ...

Health officials have issued a '48-hour' plea to parents following a rise of norovirus cases in recent weeks, particularly ...

COVID-19 is in the “High” category in Essex Junction and Montpelier, and in the “Medium” category in South Burlington. There ...

Duchon added, “If you’ve had hand, foot and mouth and afterwards, or towards the end of the virus, you’re feeling really, ...

Q3 2025 Earnings Call Transcript November 6, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-0.51282, expectations were $-2.15. Operator: Good day, and thank you for standing by.

Reports third quarter revenue of $1.0 billion, GAAP net loss of $ (0.2) billion and GAAP EPS of $ (0.51) Improves 2025 ...

Get the latest insights from Moderna's Q3 2025 earnings call: revenue guidance updates, cost reduction highlights, and pipeline progress.